Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Biomea Fusion, Inc.
NASDAQ:BMEA
Intrinsic Alpha fair value
Locked
Current Price
$0.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
CAMP4 Therapeutics Corporation NASDAQ:CAMP | $198.93M | $3.17 | Not rated | -2.8 | +13.96% |
Sutro Biopharma, Inc. NASDAQ:STRO | $181.40M | $10.94 | Not rated | -0.0 | +2.95% |
ALX Oncology Holdings Inc. NASDAQ:ALXO | $146.57M | $1.06 | Not rated | -0.9 | -25.00% |
Cibus, Inc. NASDAQ:CBUS | $100.89M | $1.32 | Not rated | -8.6 | -2.38% |
Immunic, Inc. NASDAQ:IMUX | $95.10M | $6.97 | Not rated | -4.1 | +7.41% |
Unicycive Therapeutics, Inc. NASDAQ:UNCY | $92.04M | $3.36 | Not rated | -40.8 | -33.02% |
PMV Pharmaceuticals, Inc. NASDAQ:PMVP | $64.53M | $1.21 | Not rated | -0.8 | +0.00% |
Fractyl Health, Inc. Common Stock NASDAQ:GUTS | $20.56M | $1.55 | Not rated | -0.6 | +222.48% |
Continue the stock analysis
Jump to another research area for this company.